Home » Topics » BioWorld Science

BioWorld Science
RSS

Gensia's GP-3269 in phase I

June 28, 1996

TV-1901 demonstrates efficiency and safety

June 28, 1996

RhoMed/Interfilm merger complete

June 28, 1996

ChromaXome acquired by Houghten

June 28, 1996

Faulding acquires Cenovis

June 28, 1996

Targeted Genetics acquires RGene Therapeutics

June 28, 1996

Dimethaid Research to invest in Oxo Chemie

June 28, 1996

Meridian Diagnostics purchases Cambridge Biotech enteric product line

June 28, 1996

Organogenesis and MGH to collaborate on LAD development

June 28, 1996

Tripos' ChemSpace available for licensing soon

June 28, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 22, 2025.
In 2025, science’s biggest story was political
BioWorld
In 2025, science saw its breakthroughs, which BioWorld will be covering as part of our end-of-the-year wrap-up. But the biggest science story of 2025 is not about...
FDA says yes to Cytokinetics’ aficamten, now Myqorzo, in oHCM
BioWorld
Cytokinetics Inc. scored U.S. FDA marketing clearance Dec. 19 for Myqorzo (aficamten) 5-mg, 10-mg, 15-mg, and 20-mg tablets to improve functional capacity and...
Conjugating ferrocene to GPX4 inhibitors to promote ferroptosis
BioWorld Science
Small molecules that induce iron-dependent oxidative cell death known as ferroptosis can be effective against tumors that are resistant to other therapies....